BRIEF-Resverlogix explores potential of Apabetalone in phase 3 Betonmace clinical study

* Potential of Apabetalone for treatment of high-risk diabetes and CKD is being explored in co's phase 3 Betonmace clinical study
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.